Clover Health Investments Financial Statements (CLOV)
|
|
|
|
Report date
|
|
|
28.02.2022 |
01.03.2023 |
14.03.2024 |
03.03.2025 |
27.02.2026 |
|
06.05.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
1 472 |
1 097 |
1 261 |
1 371 |
1 924 |
|
2 211 |
|
Operating Income, bln rub |
|
|
-637.0 |
-286.7 |
-205.3 |
-45.7 |
-85.5 |
|
-56.9 |
|
EBITDA, bln rub |
? |
|
-569.6 |
-252.0 |
-207.6 |
-44.9 |
-83.9 |
|
-55.2 |
|
Net profit, bln rub |
? |
|
-587.8 |
-339.6 |
-213.4 |
-43.0 |
-85.5 |
|
-56.9 |
|
|
OCF, bln rub |
? |
|
-282.3 |
-203.9 |
-115.9 |
34.8 |
-66.9 |
|
57.3 |
|
CAPEX, bln rub |
? |
|
0.723 |
4.47 |
0.584 |
1.56 |
2.04 |
|
2.71 |
|
FCF, bln rub |
? |
|
-283.0 |
-208.4 |
-116.5 |
33.3 |
-69.0 |
|
54.5 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
557.8 |
390.1 |
461.3 |
410.6 |
441.4 |
|
996.1 |
|
Cost of production, bln rub |
|
|
1 551 |
993.1 |
1 005 |
1 006 |
1 568 |
|
1 272 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
16.9 |
1.36 |
0.007 |
0.000 |
0.000 |
|
0.000 |
|
|
Assets, bln rub |
|
|
950.8 |
808.6 |
570.7 |
580.7 |
541.0 |
|
697.7 |
|
Net Assets, bln rub |
? |
|
535.4 |
356.9 |
286.4 |
341.1 |
308.7 |
|
339.4 |
|
Debt, bln rub |
|
|
27.8 |
5.86 |
4.66 |
0.000 |
0.000 |
|
0.000 |
|
Cash, bln rub |
|
|
615.3 |
334.8 |
236.2 |
221.5 |
95.3 |
|
177.6 |
|
Net debt, bln rub |
|
|
-587.4 |
-328.9 |
-231.6 |
-221.5 |
-95.3 |
|
-177.6 |
|
|
Ordinary share price, rub |
|
|
3.72 |
0.930 |
0.952 |
3.15 |
2.35 |
|
1.01 |
|
Number of ordinary shares, mln |
|
|
470.9 |
476.2 |
482.2 |
490.0 |
517.2 |
|
522.2 |
|
|
Market cap, bln rub |
|
|
1 752 |
443 |
459 |
1 544 |
1 216 |
|
527 |
|
EV, bln rub |
? |
|
1 164 |
114 |
228 |
1 322 |
1 120 |
|
350 |
|
Book value, bln rub |
|
|
531 |
337 |
283 |
338 |
306 |
|
336 |
|
|
EPS, rub |
? |
|
-1.25 |
-0.71 |
-0.44 |
-0.09 |
-0.17 |
|
-0.11 |
|
FCF/share, rub |
|
|
-0.60 |
-0.44 |
-0.24 |
0.07 |
-0.13 |
|
0.10 |
|
BV/share, rub |
|
|
1.13 |
0.71 |
0.59 |
0.69 |
0.59 |
|
0.64 |
|
|
EBITDA margin, % |
? |
|
-38.7% |
-23.0% |
-16.5% |
-3.28% |
-4.36% |
|
-2.50% |
|
Net margin, % |
? |
|
-39.9% |
-31.0% |
-16.9% |
-3.14% |
-4.45% |
|
-2.58% |
|
FCF yield, % |
? |
|
-16.2% |
-47.1% |
-25.4% |
2.16% |
-5.67% |
|
10.3% |
|
ROE, % |
? |
|
-109.8% |
-95.1% |
-74.5% |
-12.6% |
-27.7% |
|
-16.8% |
|
ROA, % |
? |
|
-61.8% |
-42.0% |
-37.4% |
-7.41% |
-15.8% |
|
-8.16% |
|
|
P/E |
? |
|
-2.98 |
-1.30 |
-2.15 |
-35.9 |
-14.2 |
|
-9.26 |
|
P/FCF |
|
|
-6.19 |
-2.12 |
-3.94 |
46.4 |
-17.6 |
|
9.67 |
|
P/S |
? |
|
1.19 |
0.40 |
0.36 |
1.13 |
0.63 |
|
0.24 |
|
P/BV |
? |
|
3.30 |
1.31 |
1.62 |
4.56 |
3.98 |
|
1.57 |
|
EV/EBITDA |
? |
|
-2.04 |
-0.45 |
-1.10 |
-29.4 |
-13.4 |
|
-6.34 |
|
Debt/EBITDA |
|
|
1.03 |
1.30 |
1.12 |
4.93 |
1.14 |
|
3.22 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
0.05% |
0.41% |
0.05% |
0.11% |
0.11% |
|
0.12% |
|
| Clover Health Investments shareholders |
